Jobe James R

Director

National Health Investors, Inc.

US, Murfreesboro [HQ]

CIK 1362322

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

14,979

Price per Share :

$69.32

Equivalence :

$1,038,344.28

Transaction History

P

Form 4

14,979 Shares After Transaction

Value : $769,920.60

$51,400.00

Transaction Date : 08/30/23
- Footnotes
- Form 4
Footnotes:
No footnote found.
M

Form 4

39,979 Shares After Transaction

Value : $2,135,278.39

$1,335,250.00

Transaction Date : 08/23/24
- Footnotes
- Form 4
Footnotes:
#1 Acquired due to the net exercise of stock options granted 2/25/22, 2/24/23 and 2/23/24 with shares withheld by the Company to cover the exercise price. This transaction was completed subsequent to the execution of a Lock-Up Agreement and shares received are subject to the provisions of that agreement.
M

Form 4

49,979 Shares After Transaction

Value : $2,735,350.67

$547,300.00

Transaction Date : 08/23/24
- Footnotes
- Form 4
Footnotes:
#1 Acquired due to the net exercise of stock options granted 2/25/22, 2/24/23 and 2/23/24 with shares withheld by the Company to cover the exercise price. This transaction was completed subsequent to the execution of a Lock-Up Agreement and shares received are subject to the provisions of that agreement.
M

Form 4

59,979 Shares After Transaction

Value : $3,464,387.04

$577,600.00

Transaction Date : 08/23/24
- Footnotes
- Form 4
Footnotes:
#1 Acquired due to the net exercise of stock options granted 2/25/22, 2/24/23 and 2/23/24 with shares withheld by the Company to cover the exercise price. This transaction was completed subsequent to the execution of a Lock-Up Agreement and shares received are subject to the provisions of that agreement.
F

Form 4

28,690 Shares After Transaction

Value : $2,255,894.70

$2,460,254.07

Transaction Date : 08/23/24
- Footnotes
- Form 4
Footnotes:
#1 Acquired due to the net exercise of stock options granted 2/25/22, 2/24/23 and 2/23/24 with shares withheld by the Company to cover the exercise price. This transaction was completed subsequent to the execution of a Lock-Up Agreement and shares received are subject to the provisions of that agreement.